Literature DB >> 33458860

Effects of Solanum undatum extract (SR-T100) on photocarcinogenesis and photoaging of actinic keratosis.

Chao-Chun Yang1,2, Chin-Han Wu3, Tak-Wah Wong1,4, Feng-Jie Lai5, Kai-Che Wei6, Tzu-Kai Lin7, Chrang-Shi Lin8, Juemin Zhao9, Leihong Xiang9, Chao-Hsing Kao10, Ying-Jan Wang11, Cheng-Che Eric Lan12, Hamm-Ming Sheu10.   

Abstract

SR-T100 gel, containing solamargine extracted from Solanum undatum (synonym: Solanum incanum), had good therapeutic effects on actinic keratosis (AK) in human and ultraviolet B-induced papilloma in mice. This study aimed to investigate the immunohistochemical changes in the human skin after SR-T100 treatment. An immunohistochemical study was performed and the changes in photocarcinogenesis and photoaging markers after 16-week SR-T100 gel treatment were documented. SR-T100 gel treatment for 16 weeks resulted in complete remission in nine AK lesions and partial remission in four AK lesions. SR-T100 gel abolished the expression of mutant p53 and SOX2 and restored the expression of NOTCH1. Additionally, SR-T100 gel improved wrinkling in human skin, while restoring the expression of lamin B1 and increasing synthesis of new elastic fibers. SR-T100 gel had therapeutic effects on photocarcinogenesis and photoaging of photodamaged skin with AK.
© 2021 Japanese Dermatological Association.

Entities:  

Keywords:  zzm321990Solanum undatumzzm321990; actinic keratosis; photoaging; photocarcinogenesis; solamargine

Mesh:

Substances:

Year:  2021        PMID: 33458860     DOI: 10.1111/1346-8138.15703

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  1 in total

1.  Solamargine Alleviated UVB-Induced Inflammation and Melanogenesis in Human Keratinocytes and Melanocytes via the p38 MAPK Signaling Pathway, a Promising Agent for Post-inflammatory Hyperpigmentation.

Authors:  Juemin Zhao; Yanjun Dan; Ziqi Liu; Qianqian Wang; Min Jiang; Chengfeng Zhang; Hamm-Ming Sheu; Chrang-Shi Lin; Leihong Xiang
Journal:  Front Med (Lausanne)       Date:  2022-06-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.